I don't know Jim, the mantra has always been next year for AT. Can't see him changing that. It has worked for ten years now.
Very well said. There many of us who have been following that ever elusive carrot for years. Tokman is good at what he does, and it ain't producing shareholder value. He will always come up short. His biggest win is now behind him and it is all down side for him. I have watched posters here say one big name is worth $20 a share for a long time. Well, it doesn't get any bigger than Sony and we still can't get back to RS pricing years ago.
Do you know just how many times he has done this over the past six years? I expect nothing less from AT and I am never disappointed in his performance. It is always next year with him and it will be so again next year. We are easily satisfied just to see him smiling as i have seen over and over since ASM. I'll bet his is smiling today and I'll bet he will be smiling again in a month when he delivers his pps smashing CC. This guy will always be a Tokman.
And say what? They could just as easily prerecord a presentation unless they have something new.
Good post gary. We earned this pps by the above statements. All earned by Dr. Kim and his mouth. The street knows what we are demonstrating in the lab, they want to see human results. They are not asking for a lot. Peer Review took about fifteen months while we waited to move forward. Bad, bad judgement. All the statements made just increased the expectations and we didn't deliver. P2 results were good enough for Dr. Kim, but not the street and they showed it by blasting the pps. Every time he opens his mouth he should have 2M in his pockets to stem the sell off with a huge open market buy.
WE have the lab results, it's just that the street wants results outside of the lab, in patients. Too long a lapse. We are where we deserve to be.
Ok Mirro, I'm ready. Hope you are right on the money this time, but I am in the disappointed camp this morning.